# University of Oxford: Phase 2 study completed, 390 enrolled (Malaria,Falciparum)

**Score:** 55/100

| Field | Value |
|---|---|
| Sponsor | University of Oxford |
| Sponsor type | Academic and hospital |
| Study | A Study to Test Experimental Blood Stage Malaria Vaccine in Burkina Faso. |
| NCT ID | NCT05790889 |
| Phase | Phase 2 |
| Status | completed |
| Conditions | Malaria,Falciparum |
| Intervention types | biological |
| Target enrollment | 390 |
| Site countries | Burkina Faso |
| Posted | 2023-03-30 |
| Planned start | 2023-04-03 |
| Event | Completed |
| Event date | 2026-10-16 |
| Last update posted | 2026-10-21 |

## Why this score
- Completed: closeout, analysis and the next study ahead.
- Phase 2: multi-site, larger budget.
- 390 participants planned.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT05790889). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.